34 related articles for article (PubMed ID: 15576636)
1. Reproducibility of postprandial lipemia tests and validity of an abbreviated 4-hour test.
Weiss EP; Fields DA; Mittendorfer B; Haverkort MA; Klein S
Metabolism; 2008 Oct; 57(10):1479-85. PubMed ID: 18803956
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of postprandial total triglycerides within the TIGG model for characterizing postprandial response of glucose, insulin, and GLP-1.
Leohr J; Kjellsson MC
CPT Pharmacometrics Syst Pharmacol; 2023 Oct; 12(10):1529-1540. PubMed ID: 37667531
[TBL] [Abstract][Full Text] [Related]
3. Nutritional status and lipid profile of HIV-positive children and adolescents using antiretroviral therapy.
Contri PV; Berchielli EM; Tremeschin MH; Negrini BV; Salomão RG; Monteiro JP
Clinics (Sao Paulo); 2011; 66(6):997-1002. PubMed ID: 21808865
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a method to deliver vitamin A to macrophages.
Acharya P; Black M; Bressner G; Amengual J
Methods Enzymol; 2022; 674():363-389. PubMed ID: 36008013
[TBL] [Abstract][Full Text] [Related]
5. Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: report of four cases and review.
Duong M; Buisson M; Cottin Y; Piroth L; Lhuillier I; Grappin M; Chavanet P; Wolff JE; Portier H
Clin Cardiol; 2001 Oct; 24(10):690-4. PubMed ID: 11594416
[TBL] [Abstract][Full Text] [Related]
6. Excess Risk for Atherosclerotic Cardiovascular Outcomes Among US Adults With HIV in the Current Era.
Rosenson RS; Hubbard D; Monda KL; Reading SR; Chen L; Dluzniewski PJ; Burkholder GA; Muntner P; Colantonio LD
J Am Heart Assoc; 2020 Jan; 9(1):e013744. PubMed ID: 31880980
[TBL] [Abstract][Full Text] [Related]
7. Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution.
van Wijk JP; Cabezas MC
Int J Vasc Med; 2012; 2012():201027. PubMed ID: 21876813
[TBL] [Abstract][Full Text] [Related]
8. The impact of fasting on the interpretation of triglyceride levels for predicting myocardial infarction risk in HIV-positive individuals: the D:A:D study.
Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
J Infect Dis; 2011 Aug; 204(4):521-5. PubMed ID: 21791653
[TBL] [Abstract][Full Text] [Related]
9. Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment.
Magkos F; Mantzoros CS
Metabolism; 2011 Jun; 60(6):749-53. PubMed ID: 20965525
[No Abstract] [Full Text] [Related]
10. High throughput prediction of chylomicron triglycerides in human plasma by nuclear magnetic resonance and chemometrics.
Savorani F; Kristensen M; Larsen FH; Astrup A; Engelsen SB
Nutr Metab (Lond); 2010 May; 7():43. PubMed ID: 20470366
[TBL] [Abstract][Full Text] [Related]
11. The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN studyboxs.
Shen J; Arnett DK; Pérez-Martínez P; Parnell LD; Lai CQ; Peacock JM; Hixson JE; Tsai MY; Straka RJ; Hopkins PN; Ordovás JM
J Lipid Res; 2008 Aug; 49(8):1839-45. PubMed ID: 18420533
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone increases small dense low-density lipoprotein concentration and decreases high-density lipoprotein particle size in HIV-infected patients.
Hadigan C; Mazza S; Crum D; Grinspoon S
AIDS; 2007 Nov; 21(18):2543-6. PubMed ID: 18025896
[TBL] [Abstract][Full Text] [Related]
13. Increased lipoprotein remnant cholesterol levels in HIV-positive patients during antiretroviral therapy.
Anuurad E; Thomas-Geevarghese A; Devaraj S; Albu J; Minolfo R; El-Sadr WM; Lu G; Karmally W; Berglund L
Atherosclerosis; 2008 May; 198(1):192-7. PubMed ID: 17996872
[TBL] [Abstract][Full Text] [Related]
14. Lipid lowering effects of Momordica charantia (Bitter Melon) in HIV-1-protease inhibitor-treated human hepatoma cells, HepG2.
Nerurkar PV; Lee YK; Linden EH; Lim S; Pearson L; Frank J; Nerurkar VR
Br J Pharmacol; 2006 Aug; 148(8):1156-64. PubMed ID: 16847441
[TBL] [Abstract][Full Text] [Related]
15. Postprandial lipoprotein changes in patients taking antiretroviral therapy for HIV infection.
Stein JH; Merwood MA; Bellehumeur JB; McBride PE; Wiebe DA; Sosman JM
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):399-405. PubMed ID: 15576636
[TBL] [Abstract][Full Text] [Related]
16. Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease.
Syvänne M; Hilden H; Taskinen MR
J Lipid Res; 1994 Jan; 35(1):15-26. PubMed ID: 8138716
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia.
Shahmanesh M; Das S; Stolinski M; Shojaee-Moradie F; Jackson NC; Jefferson W; Cramb R; Nightingale P; Umpleby AM
J Clin Endocrinol Metab; 2005 Feb; 90(2):755-60. PubMed ID: 15522931
[TBL] [Abstract][Full Text] [Related]
18. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.
Groot PH; van Stiphout WA; Krauss XH; Jansen H; van Tol A; van Ramshorst E; Chin-On S; Hofman A; Cresswell SR; Havekes L
Arterioscler Thromb; 1991; 11(3):653-62. PubMed ID: 2029503
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
